Literature DB >> 17877634

Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.

Scott D Ryan1, Cory S Harris, Fan Mo, Haemi Lee, Sheng T Hou, Nicolas G Bazan, Pierre S Haddad, John T Arnason, Steffany A L Bennett.   

Abstract

The bioactive lipid mediator platelet activating factor (PAF) is recognized as a key effecter of neuronal apoptosis, yet it is not clear whether its G-protein coupled receptor (PAFR) initiates or prevents PAF neurotoxicity. Using PAFR-/- and congenic wild-type mice, we show that PAF triggers caspase-3/7 activity and neuronal death in PAFR-/- but not PAFR+/+ cerebellar granule neurons. Restoring receptor expression by recombinant adenoviral infection protected cells from PAF challenge. Neuronal death was not mediated by nitric oxide or N-methyl-d-aspartate receptor signaling given that N-nitro-l-arginine methyl ester and MK-801 did not inhibit PAF-induced neuronal loss in PAFR-/- neurons. To intervene in PAFR-independent neurotoxicity, the anti-apoptotic actions of three structurally distinct PAF antagonists were compared to a panel of plant and fungal benzoic acid derivatives. We found that the PAF antagonist BN 52021 but not FR 49175 or CV 3988 inhibited PAFR-independent neurotoxicity. Orsellinic acid, a fungal-derived benzoic acid, blocked PAF-mediated neuronal apoptosis without affecting PAFR-mediated neuroprotection. These findings demonstrate that PAF can transduce apoptotic death in primary neurons independently of its G-protein coupled receptor, that PAFR activation is neuroprotective, and that orsellinic acid effectively attenuates PAFR-independent neuronal apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877634     DOI: 10.1111/j.1471-4159.2007.04740.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

2.  Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor.

Authors:  Yuanyi Wang; Zhongwen Gao; Yiping Zhang; Shi-Qing Feng; Yulong Liu; Lisa B E Shields; Ying-Zheng Zhao; Qingsan Zhu; David Gozal; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

3.  Human Endogenous Natural Products.

Authors:  Yingjie Bai; Liyun Zhang; Xiaoguang Lei
Journal:  Prog Chem Org Nat Prod       Date:  2021

4.  Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism.

Authors:  Scott D Ryan; Shawn N Whitehead; Leigh Anne Swayne; Tia C Moffat; Weimin Hou; Martin Ethier; André J G Bourgeois; Juliet Rashidian; Alexandre P Blanchard; Paul E Fraser; David S Park; Daniel Figeys; Steffany A L Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-19       Impact factor: 11.205

5.  Platelet-activating factor attenuation of long-term potentiation in rat hippocampal slices via protein tyrosine kinase signaling.

Authors:  Benjamin Reiner; Wenwei Wang; Jianuo Liu; Huangui Xiong
Journal:  Neurosci Lett       Date:  2016-01-22       Impact factor: 3.046

6.  Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis.

Authors:  Matheus Correa-Costa; Vinicius Andrade-Oliveira; Tarcio T Braga; Angela Castoldi; Cristhiane F Aguiar; Clarice S T Origassa; Andrea C D Rodas; Meire I Hiyane; Denise M A C Malheiros; Francisco J O Rios; Sonia Jancar; Niels O S Câmara
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

Review 7.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

8.  Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor.

Authors:  Michael A Kennedy; Nazir Kabbani; Jean-Philippe Lambert; Leigh Anne Swayne; Fida Ahmed; Daniel Figeys; Steffany A L Bennett; Jennnifer Bryan; Kristin Baetz
Journal:  PLoS Genet       Date:  2011-02-10       Impact factor: 5.917

9.  Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines.

Authors:  Najam A Sharif; Shouxi Xu; Peggy E Hellberg; Iok-Hou Pang; Daniel A Gamache; John M Yanni
Journal:  Mol Vis       Date:  2009-06-06       Impact factor: 2.367

10.  Characterizing the cytoprotective activity of Sarracenia purpurea L., a medicinal plant that inhibits glucotoxicity in PC12 cells.

Authors:  Cory S Harris; Muhammad Asim; Ammar Saleem; Pierre S Haddad; John T Arnason; Steffany A L Bennett
Journal:  BMC Complement Altern Med       Date:  2012-12-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.